COVID-19 TREATMENT
A company that designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. anticipates two regulatory approvals for berotralstat in 2020,
Even more impressive, that BCRX will likely get a significant near-term boost from the success of GILD's remdesivir in the treatment of COVID-19. it will help us a lot to conquer against the PANDEMIC. let the BULLS trend here!
Even more impressive, that BCRX will likely get a significant near-term boost from the success of GILD's remdesivir in the treatment of COVID-19. it will help us a lot to conquer against the PANDEMIC. let the BULLS trend here!
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。